Kirti Manohar Kulkarni MD, Presenter: Nothing to Disclose

Sujay K. Sheth MD, Abstract Co-Author: Nothing to Disclose

Charlene A. Sennett MD, Abstract Co-Author: Nothing to Disclose

David Victor Schacht MD, Abstract Co-Author: Nothing to Disclose

Hiroyuki Abe MD, Abstract Co-Author: Consultant, Seno Medical Instruments, Inc

Breast Radiologists need to tweek the MRI interpretation threshold based on the history and reason for the MRI: e.g staging MRI vs. high risk screening MRI. This will help reduce the false positive biopsy rate and maintain the credibility of breast MRI at your institution/practice. Background symmetric enhancing breast parenchyma can sometimes give a clue towards the decision. Role of MRI phenotypes such as morphology of the lesion and kinetic data in the decision making process will be discussed.            

The cases will be presented in a quiz format. The question to be answered is: (1) Will you biopsy this lesion and why? (2) What do you think pathology may show? A radiology-pathology correlation will be shown for each case in the discussion. We will present various Pathology scenarios that can explain the enhancing lesion. Key strategies to biopsy or not biopsy the lesion will be highlighted in the discussion of each case.

http://abstract.rsna.org/uploads/2014/14005703/14005703_dytn.pdf

Kulkarni, K, Sheth, S, Sennett, C, Schacht, D, Abe, H, Decision Making Strategies to Recommend MRI Biopsy. Will You Biopsy this Lesion? Yes or No? A Radiology-Pathology Correlation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14005703.html